Prescription costs can add up quickly when you take a medication every day. For people using Gemtesa to manage overactive bladder, the monthly price may be especially important because it is a brand-name prescription medication.

So, how much does Gemtesa cost? In the United States, the average retail price without insurance is currently about $686.64 for 30 Gemtesa 75 mg tablets, which is generally a 30-day supply. Actual prices vary by pharmacy, location, insurance coverage, and available discounts.

At Canada Drugs Direct, a 30-day supply of Gemtesa 75 mg is available for $500.89, giving U.S. customers another price to consider when comparing options for filling their prescription.

What Is Gemtesa?

Gemtesa is the brand name for vibegron, a beta-3 adrenergic agonist. It is approved for adults with overactive bladder symptoms such as a sudden need to urinate, frequent urination, and urge urinary incontinence, which is accidental urine leakage associated with a strong urge to urinate. The recommended dose is one 75 mg tablet once daily.

Because treatment may be ongoing, the cost of a monthly prescription can become an important part of deciding where to fill it. Patients should not stop or switch an overactive bladder medication because of price without first speaking with their healthcare provider.

How Much Does Gemtesa Cost Without Insurance?

Without insurance, the average U.S. retail price for 30 tablets of Gemtesa 75 mg is about $686.64. Recent pharmacy pricing data also show that retail prices can differ considerably between major U.S. pharmacy chains. Several factors may affect what you ultimately pay, including:

• The pharmacy where you fill your prescription

• Your location

• Your health insurance plan

• Your deductible, copayment, or coinsurance

• Whether Gemtesa is included on your plan's formulary

• Prior authorization or step therapy requirements

• Prescription discount programs

Patients paying out of pocket can also compare international pharmacy pricing. At $500.89 for a 30-day supply, Canada Drugs Direct may offer a lower price than the current average U.S. retail cost.

U.S. customers can check Gemtesa 75 mg at Canada Drugs Direct and compare the available price with what they would pay at a local pharmacy. Gemtesa is available by prescription, so a valid prescription from a healthcare provider is required.

Is Gemtesa Covered by Medicare?

Gemtesa may be covered by some Medicare Part D plans, but coverage is not guaranteed across every plan.

Medicare Part D plans maintain their own lists of covered medications, known as formularies. A plan may also use requirements such as prior authorization, step therapy, or quantity limits. For this reason, people with Medicare should review their plan's current drug list or contact the plan directly to determine whether Gemtesa is covered. Medicare explains how Part D drug formularies and coverage rules work.

For 2026, out-of-pocket spending on drugs covered by Medicare Part D is capped at $2,100 per calendar year. Once qualifying spending reaches that limit, patients do not pay a copayment or coinsurance for covered Part D drugs for the rest of the year.

However, purchases made outside a Medicare plan may not count toward that Part D out-of-pocket limit. Medicare beneficiaries should check with their plan before paying cash for a prescription.

Other Ways to Lower the Cost of Gemtesa

If Gemtesa is difficult to afford, there are several options worth discussing before changing treatment.

Patients with commercial insurance may qualify for the Gemtesa Simple Savings Program. Through December 31, 2026, eligible patients whose insurance covers Gemtesa may pay as little as $10 for a 30-day supply or $0 for a 90-day supply. Eligible commercially insured patients whose plan does not cover Gemtesa may pay as little as $95 for a 30-day supply. Restrictions and maximum savings limits apply. Medicare, Medicaid, and other government healthcare program beneficiaries are not eligible for this program.

Your healthcare provider may also be able to help with an insurance authorization or discuss another overactive bladder treatment if cost is preventing you from filling your prescription.

For patients paying out of pocket, comparing prices is another practical step. With the average U.S. retail price currently around $686.64 for 30 tablets, the $500.89 price through Canada Drugs Direct may provide a lower-cost option for some U.S. customers. You can view Gemtesa pricing and ordering information at Canada Drugs Direct.

The amount you pay for Gemtesa ultimately depends on your insurance, pharmacy, and available savings options. Compare the total cost carefully and speak with your healthcare provider or pharmacist if medication expenses are making it difficult to continue treatment.

Frequently Asked Questions

How much does Gemtesa cost for a 30-day supply?

The current average U.S. retail price without insurance is approximately $686.64 for 30 Gemtesa 75 mg tablets. Prices vary by pharmacy and available discounts. Canada Drugs Direct offers a 30-day supply for $500.89.

Is Gemtesa covered by Medicare?

Some Medicare Part D plans may cover Gemtesa, while others may not. Coverage depends on the individual plan's formulary and may be subject to prior authorization, step therapy, or other requirements.

Can Medicare patients use the Gemtesa savings card?

No. The Gemtesa Simple Savings Program is not available to people participating in Medicare, Medicaid, or other government healthcare programs.

Why is Gemtesa so expensive?

Gemtesa is currently sold as a brand-name prescription medication. Your final cost can also be affected by insurance coverage, pharmacy pricing, deductibles, copayments, and whether your plan places Gemtesa on a preferred or non-preferred drug tier.

Can I buy Gemtesa from Canada Drugs Direct?

U.S. customers with a valid prescription can view Gemtesa through Canada Drugs Direct. Compare the total price with your U.S. pharmacy cost and insurance benefits before ordering.